These inflammatory cytokines stimulate DC cross-presentation of tumor antigens, ultimately resulting in the mobilization of tumor-specific CD8+ T cells and natural killer (NK) cells, promoting antitumor immunity [14–16]. This evidence concerns the gene CD8A and neoplasm.